Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Biobehavioral Health Sciences, School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Obesity (Silver Spring). 2021 Aug;29(8):1294-1308. doi: 10.1002/oby.23191. Epub 2021 Jul 14.
The Action for Health in Diabetes (Look AHEAD) study previously reported that intensive lifestyle intervention (ILI) reduced incident depressive symptoms and improved health-related quality of life (HRQOL) over nearly 10 years of intervention compared with a control group (the diabetes support and education group [DSE]) in participants with type 2 diabetes and overweight or obesity. The present study compared incident depressive symptoms and changes in HRQOL in these groups for an additional 6 years following termination of the ILI in September 2012.
A total of 1,945 ILI participants and 1,900 DSE participants completed at least one of four planned postintervention assessments at which weight, mood (via the Patient Health Questionnaire-9), antidepressant medication use, and HRQOL (via the Medical Outcomes Scale, Short Form-36) were measured.
ILI participants and DSE participants lost 3.1 (0.3) and 3.8 (0.3) kg [represented as mean (SE); p = 0.10], respectively, during the 6-year postintervention follow-up. No significant differences were observed between groups during this time in incident mild or greater symptoms of depression, antidepressant medication use, or in changes on the physical component summary or mental component summary scores of the Short Form-36. In both groups, mental component summary scores were higher than physical component summary scores.
Prior participation in the ILI, compared with the DSE group, did not appear to improve subsequent mood or HRQOL during 6 years of postintervention follow-up.
先前的“糖尿病患者健康行动(Look AHEAD)”研究报告称,与对照组(糖尿病支持和教育组[DSE])相比,强化生活方式干预(ILI)在近 10 年的干预中可降低 2 型糖尿病和超重或肥胖患者的新发抑郁症状,并改善健康相关生活质量(HRQOL)。本研究比较了这两组在 2012 年 9 月 ILI 结束后额外 6 年的新发抑郁症状和 HRQOL 变化。
共有 1945 名 ILI 参与者和 1900 名 DSE 参与者完成了至少四次计划的干预后评估中的一次,评估内容包括体重、情绪(通过患者健康问卷-9 测量)、抗抑郁药物使用情况和 HRQOL(通过医疗结局量表,简短形式-36 测量)。
ILI 参与者和 DSE 参与者在干预后 6 年的随访期间分别减轻了 3.1(0.3)和 3.8(0.3)公斤[表示为平均值(SE);p=0.10]。在此期间,两组之间在新发轻度或更严重的抑郁症状、抗抑郁药物使用或在简短形式-36 的物理成分总和或心理成分总和评分的变化方面均无显著差异。在这两个组中,心理成分总和评分均高于生理成分总和评分。
与 DSE 组相比,先前参与 ILI 似乎并没有在干预后 6 年的随访中改善随后的情绪或 HRQOL。